Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 13.6810.5810.926.906.65

What is the latest EV/EBIT ratio of AUROBINDO PHARMA ?

The latest EV/EBIT ratio of AUROBINDO PHARMA is 13.68 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202413.68
Mar202310.58
Mar202210.92
Mar20216.90
Mar20206.65

How is EV/EBIT of AUROBINDO PHARMA Trending?

Years EV/EBIT % Change
Mar2024 13.68
29.30
Mar2023 10.58
-3.11
Mar2022 10.92
58.26
Mar2021 6.9
3.76
Mar2020 6.65 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/EBIT ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses